@article{41b1dada6a184eb185f7c27827a8a70b,
title = "Reply",
author = "Henderson, {Lauren A.} and Friedman, {Kevin G.} and Son, {Mary Beth F.} and Kernan, {Kate F.} and Canna, {Scott W.} and Mark Gorelik and Lapidus, {Sivia K.} and Anne Ferris and Schulert, {Grant S.} and Philip Seo and Tremoulet, {Adriana H.} and Yeung, {Rae S.M.} and Karp, {David R.} and Hamid Bassiri and Behrens, {Edward M.} and Mehta, {Jay J.}",
note = "Funding Information: S upported by the American College of Rheumatology. Dr. Henderson has received consulting fees from Sobi and Pfizer (less than $10,000) and research support from the Childhood Arthritis and Rheumatology Research Alliance. Dr. Canna has received research support from AB2 Bio and IMMvention Therapeutix. Dr. Bassiri owns stock or stock options in CSL Behring. Dr. Schulert has received consulting fees from Novartis and Sobi (less than $10,000 each). Drs. Son and Mehta have received salary support from the Childhood Arthritis and Rheumatology Research Alliance. Dr. Yeung has received consulting fees from Novartis and Eli Lilly. No other disclosures relevant to this letter were reported.",
year = "2021",
month = jul,
doi = "10.1002/art.41689",
language = "English (US)",
volume = "73",
pages = "1342--1343",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "7",
}